doi.org/10.1093/annonc/mdz154.004

Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2-directed targeted therapy in the phase 2 SUMMIT ‘basket’ trial

James J. Harding

,

James M. Cleary

,

..., Sarina Anne Piha-Paul

Annals of Oncology50.50

Volume: 30, Pages: iv127 - iv127

Published: Jul 1, 2019

Abstract

No abstract.

Paper Fields

Paper Details

Title

Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2-directed targeted therapy in the phase 2 SUMMIT ‘basket’ trial

DOI

doi.org/10.1093/annonc/mdz154.004

Published Date

Jul 1, 2019

Journal

Annals of Oncology

Volume

30

Pages

iv127 - iv127

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Notes

History